logo
Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients
Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis
Fetal corticotrophin-releasing hormone mRNA, but not phosphatidylserine-exposing microparticles, in maternal plasma are associated with factor VII activity in pre-eclampsia
Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass
C reactive protein and its determinants in healthy men and women from European regions at different risk of coronary disease
Use of the PFA-100™ closure time to predict cardiovascular events in aspirin-treated cardiovascular patients
Prediction of hemorrhagic and thrombotic events in patients with mechanical heart valve prostheses treated with oral anticoagulants
Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism
Quality assurance for oral anticoagulation self management
Efficient factor VIII affinity purification using a small synthetic ligand
Selectin haplotypes and the risk of venous thrombosis
Mild hemophilia A with factor VIII assay discrepancy
The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A
Antithrombin inhibits lipopolysaccharide-induced tumor necrosis factor-α production by monocytes in vitro through inhibition of Egr-1 expression
Plasminogen activator inhibitor-1 predicts coronary in-stent restenosis of drug-eluting stents
Matrix metalloproteinases in platelet function
MMP-2 regulates human platelet activation by interacting with integrin αIIbβ3
Pennogenin glycosides with a spirostanol structure are strong platelet agonists
Reciprocal regulation of platelet responses to P2Y and thromboxane receptor activation
Factor V Leiden is associated with more distal location of deep vein thrombosis of the leg
Can blood flow assays help to identify clinically relevant differences in von Willebrand factor functionality in von Willebrand disease types 1–3?
Join ISTH